Background: Transradial access (TRA) for coronary angiography (CA) is
Introduction
The transradial approach (TRA) for coronary angiography (CA) was initially described by Campeau [1] in 1989 and for percutaneous coronary intervention (PCI) by Kiemeneij and Laarman [2] in the early 90s.
Although the technique was rapidly adopted by a few groups in Europe, Canada, the United States and Asia, widespread use has not occurred. The obvious advantage of the radial artery compared with the femoral artery is the superficiality of the vessel with no adjacent structures susceptible to be damaged during percutaneous procedures. Hence, despite the use of aggressive a ntithrombotic regimens r equired f or PCI, the artery is readily compressible, and introducer sheaths can be immediately removed upon completion o f procedures. Haemostasis can be achieved safely and rapidly using simple compressive d evices. Two meta-analyses reviewing randomised trials comparing TRA with the traditional transfemoral approach (TFA) for diagnostic coronary angiography or interventions estimated a 73% reduction in the risk of access site-related bleeding and an 80% risk reduction of major bleeding [3, 4] . These benefits are associated with earlier ambulation, increased patient comfort, and reduced duration of hospitalisation with substantial cost containment.
However, the smaller calibre of the radial artery as well as the greater anatomical variability of its vascular course and distribution in the arm has been associated with a steep learning curve resulting in an increase in procedural failure and a higher rate of cross-over to femoral route [4] . Two recent large randomised trials comparing the two access sites in acute coronary syndrome (ACS) patients revealed less access site related bleeding in the subgroup with ST elevation myocardial infarction (STEMI) [5] with a reduction of cardiac mortality in one trial [6] . In the current ESC guidelines for STEMI treatment, TRA is the preferred access route in experienced centres [7] and there is a new consensus document on how to introduce TRA in a primarly femoral access center [8] .
In 2012 we introduced TRA for coronary angiography and percutaneous coronary intervention (PCI) in ACS patients as the new standard approach at our centre, in accordance with the current guidelines. In this study we compared TFA to TRA in troponin-positive ACS patients regarding inhospital bleeding events, 
Methods
This study was a single centre prospective registry study. All patients underwent diagnostic coronary angiography for a troponin-positive ACS. TRA was encouraged and operators switched to TRA according to a current consensus document [8] (first in elective patients, then s table A CS p atients and finally in STEMI patients). All involved operators were using the TFA as a default approach for CA before this study. In the STEMI subgroup, door-to-balloon time was defined as first medical contact to TIMI III flow in the culprit vessel. If there was spontaneous TIMI III flow, the time of (successful) arterieal puncture (radial or femoral) was used to calculate door to balloon time.
The primary endpoint was (inhospital) access site-related bleeding. S econdary e ndpoints w ere t otal bleeding events (inhospital), total procedure/fluoroscopy times and dtb times (only STEMI patients), compared between the two different access sites. Bleeding events were defined according to the bleeding academic research consortium definition (BARC) [9] .
All patients gave written informed consent for the study and the study was approved by the local ethics commitee.
Statistics
Baseline characteristics of the patients are summa- 
Results
In 2012, 789 patients underwent coronary angiography as a result of a troponin-positive ACS at our institution (mean age 63.9 ± 13.0 years; 24.6% women).
TRA rate for ACS patients was around 10% in January 2012, increasing to over 60% in December 2012. A total of 502 patients had the TFA for coronary angiography compared with 287 patients with a TRA in 2012.
Patients in the TFA group were older compared with the TRA group (64.9 ± 12.6 vs 62.2 ± 13.5; p <0.01) and there were more STEMI patients in the TFA group than in the TRA group (59.7% vs 44.6%; p <0.01) (table 1). The periprocedural characteristics were comparable between the two groups except for number of vessels diseased (average of 2.0 ± 1.0 vessel disease in the TFA group vs 1.8 ± 0 .9 in the TRA group; p = 0.01) and periprocedural use of a Gp IIb/IIIa antag- (table 2) .
Discussion
Our data demonstrate that it is safe to switch from the TFA to the TRA in ACS patients without increasing dtb times, fluoroscopy times or contrast use when the technique is introduced according to a current consensus document. Additionally, the risk of access site-related bleeding is smaller with the TRA, especially in patients recieving Gp IIb/IIIa antagonists.
Coronary angiography and finally PCI through the radial approach started in the late 80s and early 90s but only recently has the reduced access site-related bleeding events in ACS patients compared with the TFA has been documented in large studies [1] [2] [3] [4] [5] [6] . One recent large randomised study showed a reduction in access site bleeding and a reduction in cardiovascular mortality with TRA in STEMI patients [6] . Another large randomised trial did not show any mortality benefit when comparing the two approaches in ACS patients but there was a reduction in access site-related bleeding (although o nly if t he A CUITY [10] bleeding criteria were used), especially in TRA experienced centres [5] . We used the BARC [9] bleeding criteria in our study, which are more sensitive than the TIMI or ACUITY criteria. The rates of bleeding events were therefore slightly higher in our study than in these randomised trials. Nevertheless, access site-related bleeding events were lower in the TRA group in Crossover rates from the TRA to the TFA were 8.1% in our study, altogether comparable to previous work (7.6%-9.6%; [5, 6] ).
A current consensus document recommends the introduction of the TRA in a stepwise manner (diagnostic coronary angiography in elective patients first, then P CI i n elective p atients followed b y PCI i n non-STEMI patients and finally STEMI patients) [8] .
In our study the switch from the TFA to the TRA in ACS patients was encouraged and the TRA rate has steadily increased in ACS patients from below 10% in January 2012 to over 60% in December 2012. Using this stepwise introduction, the fluoroscopy times and the contrast use did not differ between the TFA and TRA, and dtb times were similar in STEMI patients.
Conclusion
Introduction of the TRA in ACS patients at a centre primarily using the TFA is feasible and safe. If the current consensus document is followed when introducing the new technique, there is no increase in procedure time, contrast use or dtb time in STEMI patients. Additionally, rates of access site bleeding are lower with the TRA especially in patients receiving
Gp IIb/IIIa antagonists.
Limitations
This was a prospective registry study. The baseline characteristics, especially bleeding risk factors, were not balanced between the TFA and TRA groups. There is a clear selection bias with more complex cases in the TFA group. This is due to the introduction of TRA with elective/stable patients first, then non-STEMI patients and then STEMI patients. Not all operators switched to TRA in STEMI patients at the same time point. This is a known phenomenon when switching from TFA to TRA [11] All events were inhospital. Nothing can be said about long-term outcome.
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